| Primary separation principle | Whole blood is separated mainly by centrifugation, which distributes components according to density. | Plasma forms the upper layer, the buffy coat contains most white blood cells and platelets, and red blood cells form the lower layer. | Supports consistent processing of donated blood into components with different clinical uses. |
| Component extraction | After centrifugation, controlled pressure or a press mechanism moves selected layers through sterile tubing into satellite bags. | The process can produce red-cell, plasma, platelet-rich, or cryoprecipitate-related components, depending on the collection and processing method. | Allows one whole-blood donation to be processed for use in different patients and clinical situations. |
| Red blood cell component | Red cells are separated from plasma and the buffy coat, then stored in an approved additive solution when applicable. | A concentrated red-cell component used to improve oxygen-carrying capacity. | Provides targeted red-cell support while reducing unnecessary exposure to other blood components. |
| Plasma component | Plasma is expressed from the separated upper layer and frozen or stored according to applicable blood-bank procedures. | A fluid component containing water, electrolytes, albumin, immunoglobulins, and clotting factors. | Enables component-specific replacement of plasma and selected coagulation factors. |
| Platelet preparation | Platelets are collected from platelet-rich plasma or from the buffy-coat layer through additional processing steps. | A platelet component that contributes to primary hemostasis and platelet plug formation. | Helps blood services prepare platelet products for patients with clinically significant thrombocytopenia or platelet dysfunction. |
| Leukocyte reduction | A validated leukocyte-reduction filter or processing step removes most white blood cells from a component. | A red-cell or platelet component with a substantially reduced leukocyte content. | May reduce febrile non-hemolytic transfusion reactions and exposure to donor leukocyte antigens when clinically indicated. |
| Closed-system processing | Sterile tubing, sealed collection bags, and validated connectors help maintain a closed fluid path. | Reduced need to expose the blood product to the surrounding environment during processing. | Supports aseptic handling and helps preserve component quality when procedures are followed correctly. |
| Standardization | Controlled pressure, calibrated scales, programmed separation steps, and documented operating procedures help regulate extraction. | More reproducible component volumes and fewer manual handling variations than an entirely manual workflow. | Improves process consistency, traceability, and staff workflow in blood-processing laboratories. |
| Quality control points | Operators verify identification, weights or volumes, seals, storage conditions, and applicable component quality specifications. | Traceable products that can be released only after required checks and testing are completed. | Helps protect product integrity and supports compliance with local blood-safety requirements. |
| Why choose a separator? | The device combines controlled layer separation, component transfer, weighing, and workflow monitoring in one processing system. | Multiple blood components can be prepared from a single donation using a structured process. | Can improve efficiency, reduce manual variability, support safer handling, and help blood centers use donated blood more effectively. |